New Allosteric Inhibitors of HSP70 Have Arrived
Published On 09/20/2019 3:20 AM
Copyright © StressMarq Biosciences Inc 2018-2019 All rights reserved
We are excited to release two new allosteric inhibitors of HSP70, YM-01 and YM-08. Both products are known to reduce levels of Tau, a protein shown to involved in the development of Alzheimer’s disease.
YM-08 is unique in that it can cross the blood brain barrier, which may set it apart as a possible therapeutic drug. As inhibitors of HSP70, they have also been found to have anti-cancer activities.
YM-01 and YM-08 are available in 10mg and 25 mg sizes to suit your research needs.
Product Name
|
Formula | MW |
Catalog No.
|
---|---|---|---|
YM-01 HSP70 Inhibitor |
C20H20ClN3OS2
|
417.97
|
|
YM-08
HSP70 Inhibitor |
C19H17N3OS2
|
367.49
|
BHB11900013 |
This entry was posted in
Product Literature